74 related articles for article (PubMed ID: 15761261)
1. Inhibition of malignant glioma cell growth by a survivin mutant retrovirus.
Temme A; Herzig E; Weigle B; Morgenroth A; Schmitz M; Kiessling A; Rieger MA; Schackert HK; Rieber EP
Hum Gene Ther; 2005 Feb; 16(2):209-22. PubMed ID: 15761261
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.
Blanc-Brude OP; Mesri M; Wall NR; Plescia J; Dohi T; Altieri DC
Clin Cancer Res; 2003 Jul; 9(7):2683-92. PubMed ID: 12855648
[TBL] [Abstract][Full Text] [Related]
3. Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells.
Liu T; Brouha B; Grossman D
Oncogene; 2004 Jan; 23(1):39-48. PubMed ID: 14712209
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
[TBL] [Abstract][Full Text] [Related]
5. The Survivin-mediated radioresistant phenotype of glioblastomas is regulated by RhoA and inhibited by the green tea polyphenol (-)-epigallocatechin-3-gallate.
McLaughlin N; Annabi B; Bouzeghrane M; Temme A; Bahary JP; Moumdjian R; Béliveau R
Brain Res; 2006 Feb; 1071(1):1-9. PubMed ID: 16412397
[TBL] [Abstract][Full Text] [Related]
6. Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways.
Shankar SL; Mani S; O'Guin KN; Kandimalla ER; Agrawal S; Shafit-Zagardo B
J Neurochem; 2001 Oct; 79(2):426-36. PubMed ID: 11677271
[TBL] [Abstract][Full Text] [Related]
7. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.
Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N
Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567
[TBL] [Abstract][Full Text] [Related]
8. Centrosome amplification induced by survivin suppression enhances both chromosome instability and radiosensitivity in glioma cells.
Saito T; Hama S; Izumi H; Yamasaki F; Kajiwara Y; Matsuura S; Morishima K; Hidaka T; Shrestha P; Sugiyama K; Kurisu K
Br J Cancer; 2008 Jan; 98(2):345-55. PubMed ID: 18195712
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice.
Naumann U; Bähr O; Wolburg H; Altenberend S; Wick W; Liston P; Ashkenazi A; Weller M
Gene Ther; 2007 Jan; 14(2):147-61. PubMed ID: 16957768
[TBL] [Abstract][Full Text] [Related]
10. Rottlerin sensitizes glioma cells to TRAIL-induced apoptosis by inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.
Kim EH; Kim SU; Choi KS
Oncogene; 2005 Jan; 24(5):838-49. PubMed ID: 15531913
[TBL] [Abstract][Full Text] [Related]
11. Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.
Kim EH; Kim HS; Kim SU; Noh EJ; Lee JS; Choi KS
Oncogene; 2005 Oct; 24(46):6877-89. PubMed ID: 16007142
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermia induces translocation of apoptosis-inducing factor (AIF) and apoptosis in human glioma cell lines.
Fukami T; Nakasu S; Baba K; Nakajima M; Matsuda M
J Neurooncol; 2004 Dec; 70(3):319-31. PubMed ID: 15662973
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.
Mühlethaler-Mottet A; Flahaut M; Bourloud KB; Auderset K; Meier R; Joseph JM; Gross N
BMC Cancer; 2006 Aug; 6():214. PubMed ID: 16930472
[TBL] [Abstract][Full Text] [Related]
14. The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma.
Van Houdt WJ; Haviv YS; Lu B; Wang M; Rivera AA; Ulasov IV; Lamfers ML; Rein D; Lesniak MS; Siegal GP; Dirven CM; Curiel DT; Zhu ZB
J Neurosurg; 2006 Apr; 104(4):583-92. PubMed ID: 16619663
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of TNF-alpha-induced ceramide formation in human glioma cells: P53-mediated oxidant stress-dependent and -independent pathways.
Sawada M; Kiyono T; Nakashima S; Shinoda J; Naganawa T; Hara S; Iwama T; Sakai N
Cell Death Differ; 2004 Sep; 11(9):997-1008. PubMed ID: 15131591
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of Survivin in nasopharyngeal carcinoma.
Faqing T; Zhi H; Liqun Y; Min T; Huanhua G; Xiyun D; Ya C
Exp Oncol; 2005 Jun; 27(2):96-101. PubMed ID: 15995625
[TBL] [Abstract][Full Text] [Related]
17. Mediating of caspase-independent apoptosis by cadmium through the mitochondria-ROS pathway in MRC-5 fibroblasts.
Shih CM; Ko WC; Wu JS; Wei YH; Wang LF; Chang EE; Lo TY; Cheng HH; Chen CT
J Cell Biochem; 2004 Feb; 91(2):384-97. PubMed ID: 14743397
[TBL] [Abstract][Full Text] [Related]
18. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.
McKay TR; Bell S; Tenev T; Stoll V; Lopes R; Lemoine NR; McNeish IA
Oncogene; 2003 Jun; 22(23):3539-47. PubMed ID: 12789262
[TBL] [Abstract][Full Text] [Related]
19. Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms.
Chakravarti A; Zhai GG; Zhang M; Malhotra R; Latham DE; Delaney MA; Robe P; Nestler U; Song Q; Loeffler J
Oncogene; 2004 Sep; 23(45):7494-506. PubMed ID: 15326475
[TBL] [Abstract][Full Text] [Related]
20. Caspase inhibition prevents the mitochondrial release of apoptosis-inducing factor.
Arnoult D; Karbowski M; Youle RJ
Cell Death Differ; 2003 Jul; 10(7):845-9. PubMed ID: 12815467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
